MedTrace Logo

EUS BD vs ERCP TP for Pancreatic Cancer

NCT03063554 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2017-02-24

No results posted yet for this study

Summary

This Endoscopic Ultrasound guided Biliary Drainage (EUS-BD) vs. Endoscopic Retrograde Cholangiopancreatography (ERCP-TP) trial (BILPAL) is a randomized controlled multicenter trial that will provide evidence whether or not traditional ERCP biliary drainage is to be performed in patients with obstruction in bile duct due to unresectable pancreatic head or periampullary tumor.

Conditions

  • Pancreatic Cancer
  • Pancreatic Adenocarcinoma
  • Biliary Tract Neoplasms
  • Biliary Duct Obstruction
  • Unresectable Pancreatic Cancer
  • Periampullary Cancer
  • Periampullary Carcinoma Non-Resectable

Interventions

PROCEDURE

Endoscopic Ultrasound Guided Biliary Drainage

Endoscopic Ultrasound Guided biliary drainage with stent placement;

PROCEDURE

ERCP

Endoscopic Retrograde Cholangiopancreatography with transpapillary biliary stent placement

Sponsors & Collaborators

  • Weill Medical College of Cornell University

    lead OTHER

Principal Investigators

  • Michel Kahaleh, MD · Weill Medical College of Cornell University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-10-18
Primary Completion
2018-09-01
Completion
2018-10-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03063554 on ClinicalTrials.gov